Jueqing Gu
Overview
Explore the profile of Jueqing Gu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
505
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jia H, Yu G, Yu J, Zhang X, Yang L, Wang B, et al.
J Clin Transl Hepatol
. 2023 Aug;
11(5):1003-1010.
PMID: 37577218
Background And Aims: A functional cure, or hepatitis B virus (HBV) surface antigen (HBsAg) loss, is difficult to achieve in patients with hepatitis B virus e antigen (HBeAg)-positive chronic hepatitis...
2.
Jiang P, Jia H, Qian X, Tang T, Han Y, Zhang Z, et al.
Hepatology
. 2023 Jun;
79(1):167-182.
PMID: 37368993
Background And Aims: Chronic hepatitis B (CHB) is caused by HBV infection and affects the lives of millions of people worldwide by causing liver inflammation, cirrhosis, and liver cancer. Interferon-alpha...
3.
Lv Y, Yu G, Zhang X, Gu J, Ye C, Lian J, et al.
Int J Infect Dis
. 2022 Nov;
125:278-284.
PMID: 36371013
Objectives: This study aimed to investigate the differences between elderly patients hospitalized with COVID-19 or influenza A H1N1 virus infections. Methods: We contrasted two absolute groups of patients (age ≥60...
4.
Lian J, Kuang W, Jia H, Lu Y, Zhang X, Ye C, et al.
J Med Virol
. 2022 Jul;
94(11):5475-5483.
PMID: 35836102
Hepatitis B surface antigen (HBsAg) loss or seroconversion is an ideal treatment endpoint for patients with chronic hepatitis B but is rarely achievable in hepatitis B e-antigen (HBeAg)-positive patients using...
5.
Ye C, Lv Y, Kuang W, Yang L, Lu Y, Gu J, et al.
J Med Virol
. 2022 Apr;
94(8):3613-3624.
PMID: 35365888
The Delta variant has gradually replaced the Alpha variant as the major strain of SARS-COV-2 infection worldwide. We extracted the clinical characteristics and outcomes information about 381 hospitalized patients infected...
6.
Cai H, Yang L, Lu Y, Zhang S, Ye C, Zhang X, et al.
BMC Infect Dis
. 2021 Feb;
21(1):147.
PMID: 33546633
Background: Coronavirus disease 2019(COVID-19) has spread worldwide. The present study aimed to characterize the clinical features and outcomes of imported COVID-19 patients with high body mass index (BMI) and the...
7.
Gu J, Yu G, Zhang X, Zhang S, Cai H, Ye C, et al.
Virol J
. 2021 Jan;
18(1):19.
PMID: 33441170
Background: In China, more than 20 million patients with chronic hepatitis B need antiviral treatment. Side effects of antiviral treatment such as renal complications can be problematic, particularly in an...
8.
Lian J, Jin C, Hao S, Zhang X, Yang M, Jin X, et al.
Aging (Albany NY)
. 2020 Jul;
12(14):13849-13859.
PMID: 32730223
This retrospective cohort study aimed to investigate the correlation of the neutrophil-to-lymphocyte ratio (NLR) with critical illness in older patients with COVID-19, and evaluate the prognostic power of the NLR...
9.
Ye C, Zhang S, Zhang X, Cai H, Gu J, Lian J, et al.
J Med Virol
. 2020 Jun;
92(11):2821-2829.
PMID: 32543710
Coronavirus disease 2019 (COVID-19) has become a serious public health problem worldwide. Here, we stratified COVID-19 patients based on their comorbidities to assess their risk of serious adverse outcomes. We...
10.
Hu J, Zhang X, Zhang X, Zhao H, Lian J, Hao S, et al.
J Infect
. 2020 Jun;
81(6):979-997.
PMID: 32474032
No abstract available.